JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, L.
Right arrow Articles by Rosenberg, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, L.
Right arrow Articles by Rosenberg, R. D.

J Biol Chem, Vol. 274, Issue 9, 5681-5691, February 26, 1999

Anticoagulant Heparan Sulfate Precursor Structures in F9 Embryonal Carcinoma Cells

Lijuan ZhangDagger , Keiichi Yoshida, Jian LiuDagger , and Robert D. RosenbergDagger parallel

From the Dagger  Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, the parallel  Department of Medicine, Harvard Medical School, Beth Israel Hospital, Boston, Massachusetts 02215, and  Tokyo Research Institute of Seikagaku Corp., Higashiyamato-shi, Tokyo 207, Japan

To understand the mechanisms that control anticoagulant heparan sulfate (HSact) biosynthesis, we previously showed that HSact production in the F9 system is determined by the abundance of 3-O-sulfotransferase-1 as well as the size of the HSact precursor pool. In this study, HSact precursor structures have been studied by characterizing [6-3H]GlcN metabolically labeled F9 HS tagged with 3-O-sulfates in vitro by 3'-phosphoadenosine 5'-phospho-35S and purified 3-O-sulfotransferase-1. This later in vitro labeling allows the regions of HS destined to become the antithrombin (AT)-binding sites to be tagged for subsequent structural studies. It was shown that six 3-O-sulfation sites exist per HSact precursor chain. At least five out of six 3-O-sulfate-tagged oligosaccharides in HSact precursors bind AT, whereas none of 3-O-sulfate-tagged oligosaccharides from HSinact precursors bind AT. When treated with low pH nitrous or heparitinase, 3-O-sulfate-tagged HSact and HSinact precursors exhibit clearly different structural features. 3-O-Sulfate-tagged HSact hexasaccharides were AT affinity purified and sequenced by chemical and enzymatic degradations. The 3-O-sulfate-tagged HSact hexasaccharides exhibited the following structures, Delta UA-[6-3H]GlcNAc6S-GlcUA-[6-3H]GlcNS335S±6S-IdceA2S-[6-3H]GlcNS6S. The underlined 6- and 3-O-sulfates constitute the most critical groups for AT binding in view of the fact that the precursor hexasaccharides possess all the elements for AT binding except for the 3-O-sulfate moiety. The presence of five potential AT-binding precursor hexasaccharides in all HSact precursor chains demonstrates for the first time the processive assembly of specific sequence in HS. The difference in structures around potential 3-O-sulfate acceptor sites in HSact and HSinact precursors suggests that these precursors might be generated by different concerted assembly mechanisms in the same cell. This study permits us to understand better the nature of the HS biosynthetic pathway that leads to the generation of specific saccharide sequences.


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
E. P. Girardin, S. HajMohammadi, B. Birmele, A. Helisch, N. W. Shworak, and A. I. de Agostini
Synthesis of Anticoagulantly Active Heparan Sulfate Proteoglycans by Glomerular Epithelial Cells Involves Multiple 3-O-Sulfotransferase Isoforms and a Limiting Precursor Pool
J. Biol. Chem., November 11, 2005; 280(45): 38059 - 38070.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Sports. Med.Home page
M Contini, S Pacini, L Ibba-Manneschi, V Boddi, M Ruggiero, G Liguri, M Gulisano, C Catini, and P A S Mourao
Modification of plasma glycosaminoglycans in long distance runners * Commentary
Br. J. Sports Med., April 1, 2004; 38(2): 134 - 137.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. L. Wu, M. Lech, D. L. Beeler, and R. D. Rosenberg
Determining Heparan Sulfate Structure in the Vicinity of Specific Sulfotransferase Recognition Sites by Mass Spectrometry
J. Biol. Chem., January 16, 2004; 279(3): 1861 - 1866.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
J. Chen, M. B. Duncan, K. Carrick, R. M. Pope, and J. Liu
Biosynthesis of 3-O-sulfated heparan sulfate: unique substrate specificity of heparan sulfate 3-O-sulfotransferase isoform 5
Glycobiology, November 1, 2003; 13(11): 785 - 794.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Xia, J. Chen, V. Tiwari, W. Ju, J.-P. Li, A. Malmstrom, D. Shukla, and J. Liu
Heparan Sulfate 3-O-Sulfotransferase Isoform 5 Generates Both an Antithrombin-binding Site and an Entry Receptor for Herpes Simplex Virus, Type 1
J. Biol. Chem., September 27, 2002; 277(40): 37912 - 37919.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Liu, Z. Shriver, R. M. Pope, S. C. Thorp, M. B. Duncan, R. J. Copeland, C. S. Raska, K. Yoshida, R. J. Eisenberg, G. Cohen, et al.
Characterization of a Heparan Sulfate Octasaccharide That Binds to Herpes Simplex Virus Type 1 Glycoprotein D
J. Biol. Chem., August 30, 2002; 277(36): 33456 - 33467.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
S. Hasan, G. Hosseini, M. Princivalle, J.-C. Dong, D. Birsan, C. Cagide, and A. I. de Agostini
Coordinate Expression of Anticoagulant Heparan Sulfate Proteoglycans and Serine Protease Inhibitors in the Rat Ovary: A Potent System of Proteolysis Control
Biol Reprod, January 1, 2002; 66(1): 144 - 158.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
L. Zhang, D. L. Beeler, R. Lawrence, M. Lech, J. Liu, J. C. Davis, Z. Shriver, R. Sasisekharan, and R. D. Rosenberg
6-O-Sulfotransferase-1 Represents a Critical Enzyme in the Anticoagulant Heparan Sulfate Biosynthetic Pathway
J. Biol. Chem., November 2, 2001; 276(45): 42311 - 42321.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
M. Princivalle, S. Hasan, G. Hosseini, and A. I. de Agostini
Anticoagulant heparan sulfate proteoglycans expression in the rat ovary peaks in preovulatory granulosa cells
Glycobiology, March 1, 2001; 11(3): 183 - 194.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Liu, Z. Shriver, P. Blaiklock, K. Yoshida, R. Sasisekharan, and R. D. Rosenberg
Heparan Sulfate D-Glucosaminyl 3-O-Sulfotransferase-3A Sulfates N-Unsubstituted Glucosamine Residues
J. Biol. Chem., December 31, 1999; 274(53): 38155 - 38162.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. L. McKeehan, X. Wu, and M. Kan
Requirement for Anticoagulant Heparan Sulfate in the Fibroblast Growth Factor Receptor Complex
J. Biol. Chem., July 30, 1999; 274(31): 21511 - 21514.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Zhang, R. Lawrence, J. J. Schwartz, X. Bai, G. Wei, J. D. Esko, and R. D. Rosenberg
The Effect of Precursor Structures on the Action of Glucosaminyl 3-O-Sulfotransferase-1 and the Biosynthesis of Anticoagulant Heparan Sulfate
J. Biol. Chem., July 27, 2001; 276(31): 28806 - 28813.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.